来源:新浪港股-好仓工作室2025年7月9日,基石药业(股份代号:2616)公告称,通过一般授权以“配售新股”方式融资,配售100,000,000股(约1.0亿股),募集约4.7亿港元(扣除费用后净得约4.7亿港元)。本次融资由摩根士丹利担任独家整体协调人、独家配售代理及独家账簿管理人。配售新股配售价4.72港元,较前一交易日收市价5.18港元折让约8.9%,较前五个交易日平均收市价折让约3.0%...
Source Link来源:新浪港股-好仓工作室2025年7月9日,基石药业(股份代号:2616)公告称,通过一般授权以“配售新股”方式融资,配售100,000,000股(约1.0亿股),募集约4.7亿港元(扣除费用后净得约4.7亿港元)。本次融资由摩根士丹利担任独家整体协调人、独家配售代理及独家账簿管理人。配售新股配售价4.72港元,较前一交易日收市价5.18港元折让约8.9%,较前五个交易日平均收市价折让约3.0%...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.